Zibotentan, an endothelin AD receptor antagonist, prevents Aβ-induced hypertension and maintains cerebral perfusion

Research output: Contribution to journalArticle (Academic Journal)

Fingerprint Dive into the research topics of 'Zibotentan, an endothelin AD receptor antagonist, prevents Aβ-induced hypertension and maintains cerebral perfusion'. Together they form a unique fingerprint.

Medicine & Life Sciences